» Articles » PMID: 39361285

USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years

Overview
Journal JAMA Netw Open
Specialty General Medicine
Date 2024 Oct 3
PMID 39361285
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: In May 2021, the US Preventive Services Task Force (USPSTF) issued a grade B recommendation encouraging colorectal cancer (CRC) screening among average-risk individuals aged 45 to 49 years. The patterns of screening uptake and possible socioeconomic disparities in screening in this age group remain unknown.

Objective: To evaluate changes in CRC screening uptake among average-risk individuals aged 45 to 49 years after the USPSTF recommendation was issued in 2021.

Design, Setting, And Participants: This retrospective cohort study used deidentified claims data from commercially insured Blue Cross Blue Shield beneficiaries aged 45 to 49 years across the US between January 1, 2017, and December 31, 2022.

Exposure: Publication of the May 2021 USPSTF CRC screening recommendation for adults aged 45 to 49 years.

Main Outcomes And Measures: Absolute and relative changes in screening uptake were compared between a 20-month period preceding (May 1, 2018, to December 31, 2019) and a 20-month period following (May 1, 2021, to December, 31, 2022) the USPSTF recommendation. Interrupted time-series analysis and autoregressive integrated moving average models were used to evaluate changes in screening rates, adjusting for temporal autocorrelation and seasonality.

Results: In this cohort study of 10 221 114 distinct beneficiaries aged 45 to 49 years (mean [SD] age, 47.04 [1.41] years; 51.04% female), bimonthly mean (SD) numbers of average-risk beneficiaries were 3 213 935 (31 508) and 2 923 327 (105 716) in the prerecommendation and postrecommendation periods, respectively. Mean (SD) screening uptake increased from 0.50% (0.02%) to 1.51% (0.59%) between the 2 periods (P < .001), representing an absolute change of 1.01 percentage points (95% CI, 0.62-1.40 percentage points) but no significant relative change (202.51%; 95% CI, -30.59% to 436.87%). Compared with average-risk beneficiaries residing in areas with the lowest socioeconomic status (SES), those residing in areas with the highest SES experienced the largest absolute change in screening (1.25 [95% CI, 0.77-1.74] percentage points vs 0.75 [95% CI, 0.47-1.02] percentage points), but relative changes were not significant (214.01% [95% CI, -30.91% to 461.15%] vs 167.73% [95% CI, -16.30% to 352.62%]). After the recommendation was issued, the screening uptake rate also increased fastest among average-risk beneficiaries residing in the areas with highest SES (0.24 [95% CI, 0.23-0.25] percentage points every 2 months) and metropolitan areas (0.20 [95% CI, 0.19-0.21] percentage points every 2 months).

Conclusions And Relevance: This study found that among privately insured beneficiaries aged 45 to 49 years, CRC screening uptake increased after the USPSTF recommendation, with potential disparities based on SES and locality.

Citing Articles

Cancer statistics, 2025.

Siegel R, Kratzer T, Giaquinto A, Sung H, Jemal A CA Cancer J Clin. 2025; 75(1):10-45.

PMID: 39817679 PMC: 11745215. DOI: 10.3322/caac.21871.


Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the global burden of disease study 2021.

Jiang J, Xie Z, Wang Q, Wang B, Huang R, Xu W BMC Public Health. 2025; 25(1):43.

PMID: 39762826 PMC: 11702109. DOI: 10.1186/s12889-024-21192-3.


When Should Colon Cancer Screening Begin? The Impact of Early-Onset Colorectal Cancer and the Reality of an Unscreened Older Population.

Lansdorp-Vogelaar I, Rabeneck L Dig Dis Sci. 2024; .

PMID: 39724471 DOI: 10.1007/s10620-024-08738-6.


Disparities in Colorectal Cancer Screening Before and After the Onset of the COVID Pandemic.

Siddique S, Wang R, Gaddy J, Stempel J, Warren J, Gross C J Gen Intern Med. 2024; 40(3):611-619.

PMID: 39495455 PMC: 11861447. DOI: 10.1007/s11606-024-09153-3.

References
1.
. Coverage of certain preventive services under the Affordable Care Act. Final rules. Fed Regist. 2013; 78(127):39869-99. View

2.
Levin T, Corley D, Jensen C, Schottinger J, Quinn V, Zauber A . Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018; 155(5):1383-1391.e5. PMC: 6240353. DOI: 10.1053/j.gastro.2018.07.017. View

3.
Bernal J, Cummins S, Gasparrini A . Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2016; 46(1):348-355. PMC: 5407170. DOI: 10.1093/ije/dyw098. View

4.
Zhang J, Chen G, Li Z, Zhang P, Li X, Gan D . Colonoscopic screening is associated with reduced Colorectal Cancer incidence and mortality: a systematic review and meta-analysis. J Cancer. 2020; 11(20):5953-5970. PMC: 7477408. DOI: 10.7150/jca.46661. View

5.
Fisher D, Princic N, Miller-Wilson L, Wilson K, Fendrick A, Limburg P . Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk. JAMA Netw Open. 2021; 4(9):e2122269. PMC: 8414191. DOI: 10.1001/jamanetworkopen.2021.22269. View